|Base Year Market Size
|USD 19.05 Billion
|Forecast Year Market Size
|USD 29.3 Billion
|Fastest Growing Market
Dialysis machine market size was valued at USD 19.05 billion in 2022. It is projected to reach USD 29.3 billion by 2031, growing with a CAGR of 4.9% during the forecast period (2023–2031).
Dialysis is a process used to eliminate wastes from the blood, such as urea and creatinine when kidney function is inadequate. It is often required for patients with chronic renal failure. During this procedure, the electrolyte balance is restored, the blood is purified, and excess fluid and toxins are eliminated. Dialysis machines filter patients’ blood in several situations, including kidney damage, kidney failure, kidney dysfunction, and removing excess waste and impurities from the kidneys. The number of patients with end-stage renal disease (ESRD) is rapidly increasing due to an aging population and an increase in chronic diseases. Additionally, dialysis is preferable to kidney transplantation, which is anticipated to boost the dialysis industry's growth.
The geriatric population is highly susceptible to end-stage renal disorders (ESRD), and many in the age group require regular dialysis treatment. Kidney disease is now recognized as an endemic problem, affecting more than 850 million people across the globe. The Centers for Disease Control and Prevention (CDC) reported that chronic kidney disease (CKD) affects nearly 15% of U.S. adults, about 37 million people. As per the World Population Prospects data assembled by the United Nations, the geriatric population is projected to reach about 2.1 billion by 2050. Also, as per a 2018 study by the University of California San Francisco, about two million people globally suffer from end-stage renal disorder (ESRD), further prompting the need for fast and efficient dialysis machines. Increasing chronic diseases, such as diabetes and hypertension, raise the risk of acute kidney injury. A sedentary lifestyle is one of the prime reasons responsible for the increasing incidence of kidney diseases across the globe. Low healthcare expenditure and expensive dialysis machines in underdeveloped countries hinder the market growth. In line with this, manufacturers are actively working to offer cost-effective, rapid, and accurate dialysis machines.
Advancement in the production of nanotechnology, combined with miniaturization, allows the rapid creation of portable medical devices, such as wearable dialysis machines. Wearable dialysis machines, also known as wearable artificial kidneys, are disassembled dialysis machines with separate parts attached to a belt that can be worn around the torso. Currently, in the U.S., several portable dialysis machines are undergoing clinical trials and are projected to be available commercially in the coming years. Leading market players are continuously working to develop a portable dialysis machine that can be easily used at home. Portable dialysis machines are designed primarily for home use, and their easy availability and adoption can reduce the global burden of end-stage renal disorders. Recently, NxStage Medical Inc. developed the System One portable dialysis machine that can be carried on a flight.
It is anticipated that the high cost of dialysis will constrain the demand for dialysis machines. Due to the necessity of frequent treatment, dialysis is an expensive therapy that places a financial burden on many patients. Most individuals in middle-income nations experience a significant financial strain as a result of receiving dialysis therapy. Thus, around 112 middle-income and low-income nations cannot afford this treatment, resulting in over one million deaths yearly from untreated renal failure. All of these obstacles have discouraged new entries into the dialysis industry, hence worsening the supply-demand gap.
The global dialysis machine market is bifurcated into four regions: North America, Europe, Asia-Pacific, and LAMEA.
Asia-Pacific dominates the dialysis machine market. As per the studies conducted by the International Society of Nephrology, the prevalence of chronic kidney disorder (CKD) and end-stage renal disease (ESRD) is increasing at a concerning rate in India, China, and Southeast Asia, prompting the demand for dialysis machines across the region. To date, kidney transplant is an unpopular procedure in India, further increasing the number of patients on hemodialysis. The increasing prevalence of non-communicable diseases such as diabetes, hypertension, and obesity is subsequently increasing the chances of ESRD. Thus, the unavailability of proper healthcare services, rising healthcare expenditure, and increasing geriatric population drive regional market growth. Several healthcare companies are actively working to develop affordable dialysis machines fulfilling the vital function of the treatment. The George Institute of Global Health in Australia recently won an award for the development of the world's first affordable dialysis machine that uses only a solar panel, water purifier, and care station.
North America holds a significant share of the dialysis machines market as the region is backed by the presence of well-developed healthcare infrastructure and supportive reimbursement policies. Moreover, increasing awareness regarding the benefits of dialysis and the easy availability of these machines foster regional market growth. Prominent players in the region are continuously working to develop portable dialysis machines that can be easily used at home. For instance, Outset Medical Inc, a healthcare firm based in the U.S., recently modernized and developed Tablo which incorporates the newest technology. The treatment data can be easily transmitted to cloud storage via wireless connectivity integrated with the machine, while table sensors fitted into the machine facilitates process setting by automation and enables faster real-time dialysis. Growing investments and research in the development of innovative technologies are anticipated to increase in popularity and offer ample scope. The U.S. government created a program called KidneyX to assist manufacturers in redesigning dialysis machines. These systems would give connective health as a means to facilitate treatment for patients and provide professionals with the required data.
Europe's market growth is mostly driven by the aging of its population. According to Eurostat estimates, more than one-fifth (20.6%) of the EU population will be aged 65 and older, while the proportion of those aged 80 and older is projected to increase from 5.9% in 2020 to 14.4% in 2100. In addition to causing diabetes, heart disease, and high blood pressure in the elderly, renal disease and abnormal kidney function can contribute to a number of other health issues. Consequently, early treatment of renal problems is vital. In addition, an increase in cases of end-stage renal diseases, an increase in funding for the development of new products with advanced technology, and a sharp increase in kidney failure cases will raise market demand. Germany dominates the dialysis market in Europe. Favorable reimbursement policies and the presence of important corporations will advance the industry at the regional level.
Chronic kidney disease poses a significant problem for Latin America due to its epidemic proportions and high burden on the affected population and public health systems. Increasing numbers of End-stage renal disease (ESRD) patients necessitate dialysis; thus, the number of dialysis centers is growing. The vast majority of hemodialysis patients are treated at dialysis centers. The expanding market for health insurance has prompted patients to seek better medical treatment and spend more on healthcare. The modernization of public healthcare and the upgrading of equipment will drive future expansion in dialysis treatments. The expansion of the dialysis equipment market in the Middle East can be ascribed to the rising frequency of chronic kidney illnesses and end-stage renal disorders. In addition, government initiatives to increase dialysis awareness are anticipated to fuel market expansion during the forecast period. In addition, an increasing number of technological breakthroughs in dialysis machines to treat chronic renal diseases are predicted to boost market expansion.
|By End-Use Industry
|Honeywell International Fresenius Medical Care AG & Co. KGaA Braun Melsungen AG Baxter JMS Co. Ltd. Asahi Kasei Corporation TORAY MEDICAL CO. LTD Cantel Medical Rockwell Medical Teleflex Incorporated Nipro Corporation Outset Medical
|U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
|China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
|Middle East and Africa
|UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
|Brazil Mexico Argentina Chile Colombia Rest of LATAM
|Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global dialysis machine market is segmented based on product and end-use industry.
Based on product, the market is segmented into hemodialysis equipment and peritoneal dialysis equipment.
The hemodialysis equipment segment is projected to witness exponential growth during the forecast period on account of the rising prevalence of terminal kidney failure. Hemodialysis is used to filter waste and water from the blood. The segment is largely driven by rapid product development by prominent players. Increasing accessibility of HD centers, rising number of community dialysis centers, surging awareness about HD administration, and favorable reimbursement policies foster segment growth. Apart from this, acceptance of hemodialysis therapy over peritoneal dialysis among CKD and ESRD patients also drives segment growth.
Based on the end-use industry, the dialysis machine market is segmented into hospitals & dialysis centers, and home dialysis.
The surging number of private and public dialysis centers is increasing the demand for renal dialysis machines. The segment is primarily driven by new product launches, easy availability of skilled healthcare professionals, and the presence of favorable reimbursement policies. Recently, Fresenius Medical Care AG & Co. KGaA announced plans to launch eight new centers in collaboration with John Hopkins Hospital.